TABLE OF CONTENTS
Volume 34, Issue 9 (November (1) 2004)
Mini Review |
Meeting Report |
Conditioning Regimens |
Allografting |
Case Report |
Correspondence |
Errata
Editorial
The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis FREE
R K Burt, K Kallunian, D Patel, J Thomas, A Yeager, A Traynor, F Heipe, R Arnold, A Marmont, D Collier, E Glatstein and J Snowden
Bone Marrow Transplant 34: 745-751; advance online publication, September 13, 2004; doi:10.1038/sj.bmt.1704671
Mini Review
Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? FREE
K R Cooke and G Yanik
Bone Marrow Transplant 34: 753-765; advance online publication, August 9, 2004; doi:10.1038/sj.bmt.1704629
Meeting Report
An update on graft-versus-host and graft-versus-leukemia reactions: a summary of the sixth International Symposium held in Schloss Ellmau, Germany, January 22–24, 2004 FREE
R Munker, C Schmid, J A Madrigal and H J Kolb
Bone Marrow Transplant 34: 767-780; advance online publication, September 13, 2004; doi:10.1038/sj.bmt.1704667
Conditioning Regimens
High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma – a retrospective evaluation FREE
T Demirer, M Ayli, T Fen, M Ozcan, M Arat, S Buyukberber, O Arslan, G Gurman, H Akan and O Ilhan
Bone Marrow Transplant 34: 781-786; advance online publication, September 6, 2004; doi:10.1038/sj.bmt.1704672
Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0 FREE
M Sakiyama, M Kami, A Hori, O Imataki, T Hamaki, N Murashige, K Kobayashi, Y Kishi, R Kojima, S-W Kim, E Kusumi, K Yuji, S Miyakoshi, S Mori, R Tanosaki, S Taniguchi and Y Takaue for the Tokyo SCT Consortium
Bone Marrow Transplant 34: 787-794; advance online publication, September 13, 2004; doi:10.1038/sj.bmt.1704673
Allografting
Favorable outcome of allogeneic hematopoietic stem cell transplantation for relapsed or refractory acute promyelocytic leukemia in childhood FREE
J P Bourquin, I Thornley, D Neuberg, L Brennan, A Kung, J Clark, L Lehmann and E C Guinan
Bone Marrow Transplant 34: 795-798; advance online publication, September 6, 2004; doi:10.1038/sj.bmt.1704676
Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia FREE
E R Nemecek, T A Gooley, A E Woolfrey, P A Carpenter, D C Matthews and J E Sanders
Bone Marrow Transplant 34: 799-806; advance online publication, September 13, 2004; doi:10.1038/sj.bmt.1704689
Outcome of allogeneic stem cell transplantation in patients with myelofibrosis FREE
M Ditschkowski, D W Beelen, R Trenschel, M Koldehoff and A H Elmaagacli
Bone Marrow Transplant 34: 807-813; advance online publication, September 6, 2004; doi:10.1038/sj.bmt.1704657
Case Report
Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole FREE
V H Bigley, R F Duarte, R D Gosling, C C Kibbler, S Seaton and M Potter
Bone Marrow Transplant 34: 815-817; advance online publication, September 13, 2004; doi:10.1038/sj.bmt.1704660
Correspondence
Pericarditis occurring with engraftment syndrome in a thalassemic patient FREE
S Pakakasama, S Wanitkun and S Hongeng
Bone Marrow Transplant 34: 819-820; advance online publication, September 13, 2004; doi:10.1038/sj.bmt.1704666
T-cell post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: another case and a review of the literature FREE
L G Lau, L K Tan, M Salto-Tellez, E S C Koay and T C Liu
Bone Marrow Transplant 34: 821-822; advance online publication, September 6, 2004; doi:10.1038/sj.bmt.1704677
West Nile virus infection in bone marrow transplant patients FREE
K B Robertson, M A Barron and Y Nieto
Bone Marrow Transplant 34: 823-824; advance online publication, September 13, 2004; doi:10.1038/sj.bmt.1704684
Successful allogeneic haematopoietic stem cell transplantation in patients with poor-risk leukaemia and prior invasive fungal infection FREE
P Mehta, B Augustson, S Krishnamurthy, A Jacob, D Roy, J Olliff, M Cook, C Craddock and P Mahendra
Bone Marrow Transplant 34: 825-826; advance online publication, September 13, 2004; doi:10.1038/sj.bmt.1704685
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias FREE
M Tiribelli, L Marin, E Calistri, A Geromin, D Damiani and R Fanin
Bone Marrow Transplant 34: 827-828; advance online publication, August 30, 2004; doi:10.1038/sj.bmt.1704687
The thymus is typically small at 1 year after autologous or allogeneic T-cell-replete hematopoietic cell transplantation into adults FREE
J Storek, J H Staver, B A Porter and D G Maloney
Bone Marrow Transplant 34: 829-830; advance online publication, August 2, 2004; doi:10.1038/sj.bmt.1704635
Inflammatory pseudotumor of the kidney arising after unrelated bone marrow transplantation FREE
K Ogura, T Ikeda, S Kobayashi, H Torikai, K Sato, F Kimura and K Motoyoshi
Bone Marrow Transplant 34: 831-832; advance online publication, August 23, 2004; doi:10.1038/sj.bmt.1704648
Errata
Psychosocial supportive care for children receiving stem cell transplantation: practice patterns across centers FREE
A C Sherman, S Simonton, U Latif, L Nieder, R H Adams and P Mehta
Bone Marrow Transplant 34: 833; doi:10.1038/sj.bmt.1704731
